My 5c worth - Another way of viewing the estimated share price is as follows (in AUD):
Value of 25% CCJ option in GLE = $0.35B AUD = ~ $2 per share (see ref below of GLE valuation by RDC = 1.3B CAD)
Royalty income stream from Paducah = $0.25B AUD = ~ $1.5 per share (5M lbs * 50 USD/lb * 7% * 10 PE)
The remaining 26% of GLE that SLX holds = ~$2 per share (as above)
TOTAL = $5.50 AUD per share
This share price value DOES NOT include
Royalty income from HALEU = who knows - potentially very large - see Segra ref below
Royalty income from LEU (above and beyond the 5m lbs p.a. from the DOE) = who knows - potentially very large DOE have a lot of waste UF6
ZSS income = who knows
Tax / Govt Incentives = Not sure
References:Segra's estimates https://segracapital.com/commentary/the-advanced-nuclear-fuel-cycle-we-can-work-it-out/
- Segra HALEU estimates:
https://twitter.com/uraniumequities/status/1554091652091985920?s=12&t=ztwprbWLNuHvFDrM1BBiNA
- GLE Valuation of 1.3B is here
![]()
- Forums
- ASX - By Stock
- Todays fair value for SLX
SLX
silex systems limited
Add to My Watchlist
0.00%
!
$4.29

My 5c worth - Another way of viewing the estimated share price...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.29 |
Change
0.000(0.00%) |
Mkt cap ! $1.021B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 521 | $4.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.08 | 235 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 121 | 4.180 |
4 | 2876 | 4.170 |
4 | 1723 | 4.160 |
8 | 24561 | 4.150 |
4 | 1654 | 4.140 |
Price($) | Vol. | No. |
---|---|---|
4.210 | 1364 | 5 |
4.220 | 9225 | 6 |
4.230 | 2027 | 6 |
4.240 | 1556 | 4 |
4.250 | 1252 | 3 |
Last trade - 09.58am 07/07/2025 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online